Article Details

C4X Discovery agrees licensing deal with Sanofi

Retrieved on: 2021-04-12 08:48:45

Tags for this article:

Click the tags to see associated articles and topics

C4X Discovery agrees licensing deal with Sanofi. View article details on hiswai:

Excerpt

Currently, treatments that target IL-17 are monoclonal antibodies that are ... “While antibody therapies have demonstrated the potential of IL-17 ...

Article found on: www.pharmatimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up